Kane Biotech Inc. KNE.V
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -49.11% | -17.59% | 163.67% | 67.30% | 60.28% |
| Total Receivables | -72.16% | -85.13% | -56.54% | -83.83% | -68.15% |
| Inventory | 37.91% | 211.59% | 40.83% | -52.23% | -53.86% |
| Prepaid Expenses | -36.80% | -35.94% | 25.65% | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -36.70% | -6.59% | 72.28% | -26.72% | 2.23% |
|
|
|||||
| Total Current Assets | -36.70% | -6.59% | 72.28% | -26.72% | 2.23% |
| Net Property, Plant & Equipment | -90.65% | -89.92% | -46.19% | -49.70% | -14.37% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -3.61% | 0.95% | 11.25% | -24.23% | -21.61% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -43.85% | -32.34% | 15.03% | -31.94% | -6.12% |
|
|
|||||
| Total Accounts Payable | 7.45% | 30.19% | -27.81% | 71.46% | 103.80% |
| Total Accrued Expenses | -- | -- | -37.37% | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 135.23% | 176.85% | 201.28% | 34.48% | 22.64% |
| Total Finance Division Other Current Liabilities | -77.25% | -88.21% | -64.85% | -- | -78.01% |
| Total Other Current Liabilities | -77.25% | -88.21% | -64.85% | -- | -78.01% |
| Total Current Liabilities | 24.01% | 15.96% | 8.94% | -34.70% | -30.01% |
|
|
|||||
| Total Current Liabilities | 24.01% | 15.96% | 8.94% | -34.70% | -30.01% |
| Long-Term Debt | -53.66% | -23.93% | -32.42% | 21.60% | 20.87% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -49.76% | -55.43% | -14.56% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -23.52% | -14.51% | -11.42% | -25.39% | -15.33% |
|
|
|||||
| Common Stock & APIC | 0.44% | 8.74% | 16.66% | 6.53% | 12.53% |
| Retained Earnings | -3.25% | -9.38% | -13.24% | -6.47% | -10.33% |
| Treasury Stock & Other | 2,035.85% | 2.97% | -76.81% | -78.64% | -89.68% |
| Total Common Equity | -306.21% | -28.80% | 51.91% | -11.75% | 67.32% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -306.21% | -28.80% | 51.91% | -11.75% | 67.32% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -306.21% | -28.80% | 51.91% | -11.75% | 67.32% |
|
|
|||||